In late September, Hurricane Helene flooded Baxter’s site, spawning a national shortage of IV fluids and prompting some hospitals to delay surgeries. The American Society of Health-System Pharmacists surveyed 401 of its members from Oct. 16-25 to assess the severity of the shortage.
Three-fourths of respondents said Baxter is their facility’s main supplier of large-volume fluids. The most common mitigation strategies included converting infused medications to injection or intramuscular administration (71% of respondents), rationing fluids for specific clinical indications (60%) and implementing oral hydration protocols (58%).
Among respondents who are in charge of purchasing and inventory management, 47% reported their current inventory of large-volume fluids is down to two weeks’ supply or less, the survey found.
On Nov. 7, Baxter said it expects to soon manufacture 85% of its pre-Helene supply of 1-liter units of IV solution — the most common size used by hospitals and clinics. The North Carolina site is currently producing 50% of its normal output of 1-liter IV bags.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
